{"symbol":"ABBV","fiscalQuarter":"Q4-2023","reportDate":"2024-02-02","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2023","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 0.64%","keyNumbers":[{"metric":"EPS","actual":"$2.79","expected":"N/A","surprise":"+1.16%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted the strength of their product pipeline.","They emphasized ongoing commitment to innovation and market expansion.","No specific guidance was provided for future quarters."],"summary":"Overall, management expressed confidence in their current strategies and product offerings. However, they did not provide specific guidance for future performance."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"AbbVie's earnings report shows a positive surprise on EPS, which contributed to a slight increase in stock price. The lack of revenue data and future guidance may leave investors cautious. Overall, the company appears to be focusing on its product pipeline and innovation moving forward.","metaDescription":"AbbVie Inc (ABBV) Q4 2023 earnings: EPS beat by 1.16%. Stock up 0.64%. Full breakdown."}}